5 papers and 0 clinical trials exploring lsd as a treatment for personality disorders.
LSD is a classic psychedelic ergoline with high potency at microgram doses and an 8-12 hour duration of action, mediated primarily via 5-HT2A receptor agonism. Modern Phase IIb data in generalised anxiety disorder and FDA Breakthrough Therapy Designation for MM120 have reignited clinical development.
Full LSD profilePersonality disorders, characterised by enduring patterns of behaviour, cognition, and inner experience, present substantial challenges in treatment. Emerging research into psychedelics such as psilocybin, MDMA, and ketamine indicates that they may offer novel therapeutic avenues for addressing these complex conditions.
Full Personality Disorders profileNo clinical trials have been tagged with both LSD and Personality Disorders yet.
Trials are continuously being added as new studies are registered.